Collectively, these data demonstrate that KLF5 overexpression regulates ERBB2 expression in AR-positive prostate cancer cells and more broadly regulates ERBB2-related genes LGALS7 and FAM129B in prostate cancer cells regardless of cellular AR status. This evidence concerns the gene AR and prostate carcinoma.